Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-POINT: Oral Insulin for T1D Prevention
NCT02620553Phase 2Completed
- Sponsor
- University of Colorado Denver
- Start
- Sep 2007
- Primary completion
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of regular human insulin in type 1 diabetes mellitus (T1D), sponsored by University of Colorado Denver. Started Sep 2007; status: completed.
02
Drugs
regular human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02620553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02620553.